News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Thermo Fisher Scientific's Monza, Italy Manufacturing Facility Secures GMP Approval from the Italian Medicines Agency (AIFA) for RNA-Based Products
Friday, January 19, 2024Thermo Fisher Scientific a prominent player in advancing scientific solutions globally has recently obtained Good Manufacturing Practice approval from the Italian Medicines Agency for its Monza facility in Italy
PeproMene Bio Reports Success in Phase 1 Trial for PMB-CT01 in B-ALL at City of Hope
Friday, January 19, 2024PeproMene Bio Inc a biotech company in the clinical stage dedicated to developing innovative therapies for cancer and immune diseases has announced that the initial patient in Cohort of the phase clinical trial involving PMBCT
Alcami Finalizes Acquisition of Pacific Pharmaceutical Services on the West Coast
Thursday, January 18, 2024Alcami Corporation a leading contract development and manufacturing organization has announced the successful completion of its acquisition of Pacific Pharmaceutical Services Inc a provider of cGMP pharma storage and services
ERS Genomics and StemSight Enter into CRISPR/Cas9 Licensing Agreement
Thursday, January 18, 2024ERS Genomics Limited a company focused on CRISPR licensing and formed to facilitate broad access to the foundational CRISPRCas intellectual property coowned by Dr Emmanuelle Charpentier has entered into a nonexclusive CRISPRCas license
EpiVario Finalizes Acquisition of ACSS2 Inhibitor Portfolio from Metabomed LTD
Wednesday, January 17, 2024EpiVario Inc a leading biotechnology company specializing in neuroepigenetics for the treatment of addiction disorders has recently finalized an asset purchase agreement with Metabomed LTD This agreement involves the acquisition of Metabomeds portfol...
Accurus Biosciences and ImmPACT Bio Establish Exclusive Global Licensing Agreement for a Promising CLDN18.2 Antibody with Potential Best-in-Class Attributes
Wednesday, January 17, 2024Accurus Biosciences Inc is delighted to announce the initiation of a global licensing agreement for its CLDN monoclonal antibody with ImmPACT Bio USA Inc a clinicalstage company dedicated to advancing nextgeneration
Andelyn Biosciences, Armatus Bio Partner for CMT1A Gene Therapy
Tuesday, January 16, 2024Andelyn Biosciences Inc a prominent Contract Development and Manufacturing Organization specializing in cell and gene therapy has formed a strategic partnership with Armatus Bio to expedite the manufacturing process for their gene therapy
PharmAlliance Finalizes Purchase of Monitor for Hire
Friday, January 12, 2024PharmAlliance a diversified pharmaceutical and life sciences services provider is excited to announce its recent acquisition of Monitorforhire a robust business recognized for its online system that connects clinical research monitors
Fortrea Collaborates With Veeva and Advarra to Improve Patient and Site Experiences in Clinical Trials
Thursday, January 11, 2024Fortrea has recently announced a strategic industry collaboration with key partners Veeva Systems Inc and Advarra forming a leading global contract research organization Veeva a major provider of cloud solutions
Ariceum Therapeutics Initiates Application for UK Clinical Trial Authorization to Evaluate First-of-its-Kind Iodine-123 Labeled PARP Inhibitor in Patients with Recurrent Glioblastoma
Thursday, January 11, 2024Ariceum Therapeutics a private biotech company focused on developing radiopharmaceutical products for challenging cancers has officially submitted an application to the UKs Medicines and Healthcare products Regulatory Agency
